QCOM vs SGMO · P/E 16, rev $44.28B vs rev $57.8M
Qualcomm Incorporated (QCOM) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
QCOM currently screens at market cap $175.02B and trailing P/E 16.3. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the QCOM and SGMO stock pages for the full models.
Not investment advice.